Bishal Gyawali/scri.queensu.ca
Aug 6, 2025, 06:33
Bishal Gyawali: How to Improve the Success Rates of Phase 3 Oncology Trials
Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn about recent paper he and colleagues co-authored:
“Our new editorial published today in Journal of National Cancer Institute.
Here we discuss how to improve the success rates of phase 3 oncology trials. Open access.”
Title: Success in oncology phase 3 trials: a small P value or patient value
Authors: Laure-Anne Teuwen, Gregory R. Pond, Bishal Gyawali
Read The Full Article at Journal of National Cancer Institute.
More posts featuring Bishal Gyawali.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 6, 2025, 06:26
Aug 6, 2025, 05:59
Aug 6, 2025, 05:45
Aug 6, 2025, 05:24
Aug 6, 2025, 04:54